Omeros (OMER) Capital Expenditures Growth (3y) (2013 - 2025)
Omeros (OMER) Capital Expenditures Growth (3y) (2013 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Capex Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
- |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
- |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
- |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
- |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
46.88% |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
- |
| 10 |
Omeros |
628.56 Mn |
493.24 Mn |
9.31 Mn |
- |
| Date | Value |
|---|
| Sep 30, 2025 |
78.28% |
| Dec 31, 2024 |
-29.44% |
| Sep 30, 2024 |
-78.67% |
| Jun 30, 2024 |
-3.13% |
| Mar 31, 2024 |
69.08% |
| Sep 30, 2023 |
-23.25% |
| Jun 30, 2023 |
24.07% |
| Dec 31, 2022 |
-6.69% |
| Sep 30, 2022 |
-27.59% |
| Dec 31, 2021 |
-7.33% |
| Sep 30, 2021 |
5.39% |
| Jun 30, 2021 |
-24.32% |
| Mar 31, 2021 |
-59.67% |
| Sep 30, 2020 |
29.01% |
| Jun 30, 2020 |
-16.12% |
| Mar 31, 2020 |
-2.86% |
| Dec 31, 2019 |
-30.66% |
| Sep 30, 2019 |
-3.94% |
| Jun 30, 2019 |
41.83% |
| Dec 31, 2018 |
20.62% |
